银行股破净71%，铁路股跌掉31%，房地产龙头亏掉87%！抄底者遭遇腰斩

Core Viewpoint - The article discusses the significant decline in stock prices of several companies, highlighting the disconnect between attractive valuation metrics and actual market performance, leading to investor confusion and losses. Group 1: Company Performance - Daqin Railway's stock price has fallen from 7.17 yuan in July 2025 to below 5 yuan by January 2026, with a total decline of 31% over the past six months [5][12] - Minsheng Bank's stock price has dropped to 3.76 yuan, representing a 32% loss for investors who bought in the last six months, with a price-to-earnings ratio of 5.42 and a net asset value of 12.83 yuan [7][10] - Vanke A's stock has plummeted from a peak of 36 yuan to 4.7 yuan, with an 87% cumulative decline and a 52% drop in the past year [12][14] - Yongtai Energy's stock price has remained below 2 yuan, with a recent brief increase due to a buyback announcement, but quickly returned to 1.62 yuan [17][19] Group 2: Market Dynamics - The decline in these stocks is attributed to fundamental changes in their respective industries, such as the decline of coal transportation for Daqin Railway and the real estate downturn affecting Minsheng Bank [19][20] - The presence of a large number of retail investors with dispersed holdings has led to a lack of coordinated buying power, exacerbating the downward pressure on stock prices [21][22] - Investors are falling into psychological traps, misjudging the value based on past prices and static valuation metrics, leading to repeated miscalculations of the bottom [23][25] Group 3: Valuation and Future Outlook - The article emphasizes that traditional valuation metrics like price-to-earnings ratios can be misleading if future earnings are expected to decline significantly, potentially leading to a situation where a seemingly low valuation becomes high [24][25] - The market is undergoing a severe revaluation process, focusing on current realities and future expectations rather than past performance, which is causing significant pain for previously well-regarded stocks [26]